Astec Lifesciences Ltd
NSE:ASTEC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
827.75
1 458.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Astec Lifesciences Ltd
Total Liabilities & Equity
Astec Lifesciences Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Astec Lifesciences Ltd
NSE:ASTEC
|
Total Liabilities & Equity
₹8.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
UPL Ltd
NSE:UPL
|
Total Liabilities & Equity
₹851.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Fertilisers And Chemicals Travancore Ltd
NSE:FACT
|
Total Liabilities & Equity
₹58.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Bayer Cropscience Ltd
NSE:BAYERCROP
|
Total Liabilities & Equity
₹46B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
PI Industries Ltd
NSE:PIIND
|
Total Liabilities & Equity
₹107.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Coromandel International Ltd
NSE:COROMANDEL
|
Total Liabilities & Equity
₹169.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
Astec Lifesciences Ltd
Glance View
Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. The company is headquartered in Mumbai, Maharashtra and currently employs 506 full-time employees. The company went IPO on 2009-11-25. The firm operates through the Agrochemicals segment. The company manufactures a range of fungicides, insecticides, herbicides and intermediates for its global customers. The Company’s product and intermediates include triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans and heterocyclic sulfonyl chlorides. The company has two multipurpose production sites at Mahad.
See Also
What is Astec Lifesciences Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
8.8B
INR
Based on the financial report for Sep 30, 2024, Astec Lifesciences Ltd's Total Liabilities & Equity amounts to 8.8B INR.
What is Astec Lifesciences Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
11%
Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for Astec Lifesciences Ltd have been 7% over the past three years , 11% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet